KIA
EBS icon

King Investment Advisors’s Emergent Biosolutions EBS Stock Holding History

King Investment Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-54,750
Closed -$1.04M – 121
2013
Q3 		$1.04M Sell
54,750
-31,260
-36% -$558K 0.45% 53
2013
Q2 		$1.24M Buy
+86,010
New +$1.25M 0.51% 47

Other funds holding EBS

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

King Investment Advisors's EBS Position: Q4 2013 in Review

King Investment Advisors sold out of Emergent Biosolutions (EBS) in Q4 2013, closing a stake of 54,750 shares — an estimated $1.04M sold.

King Investment Advisors first reported a position in EBS in Q2 2013 and held it in 2 quarters. The position peaked at $1.24M in Q2 2013. 132 funds tracked by Wall St. Rank hold EBS as of Q4 2013.

  • King Investment Advisors reported no remaining Emergent Biosolutions position as of Q4 2013 after selling out during the quarter.
  • King Investment Advisors sold 54,750 Emergent Biosolutions shares in Q4 2013, an estimated $1.04M.
  • King Investment Advisors first reported a position in Emergent Biosolutions in Q2 2013 and held it in 2 quarters.
  • King Investment Advisors's Emergent Biosolutions position peaked at $1.24M in Q2 2013.
  • 132 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2013.

Based on King Investment Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.